TrialDiabetologia2020

Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study.

Michelle Rosenzwajg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.